申请人:SmithKline Beecham Corporation
公开号:US20020128321A1
公开(公告)日:2002-09-12
This invention relates to novel compounds and a novel use of phenyl ureas in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
本发明涉及新型化合物和苯基脲在治疗由趋化因子Interleukin-8(IL-8)介导的疾病状态中的新用途。